drugset / Trial / NCT03372629
A Study to Evaluate if ID-085 is Safe, Its Fate in the Body as Well as Its Potential Effects on the Body in Healthy Subjects
RandomizedSingle-groupQuadruple-blindOther
Summary
The objective of this study is to evaluate the tolerability, safety, and pharmacokinetic of single- and multiple-ascending doses of ID-085 in healthy subjects.
Timeline
- Start
- 2018-01-12
- Primary completion
- 2018-12-02
- Completion
- 2018-12-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ID-085 | Unknown | 10 mg | Oral |
| Subject | ID-085 | Unknown | 30 mg | Oral |
| Subject | ID-085 | Unknown | 100 mg | Oral |
| Subject | ID-085 | Unknown | 200 mg | Oral |
Indications
No indication recorded.